Background: Quadratus lumborum block (QLB) provides a reduction in pain scores and opioid consumption after cesarean section (CS). Intrathecal morphine (ITM) is still considered as the gold standard of acute postoperative pain therapy, but it does have some significant side effects. The aim of this clinical study was to evaluate whether performing the quadratus lumborum block type I in patients undergoing CS would be associated with an increased satisfaction of pain therapy and a decreased incidence of chronic postsurgical pain (CPSP). Methods: Sixty patients scheduled for elective CS were enrolled. All patients received spinal anesthesia and were randomly allocated to either the QLB group (received bilateral quadratus lumborum block type I with the use of 24 m mL 0.375% ropivacaine) or the control group (received no block). The level of satisfaction was evaluated using a three-step scale and the answers provided in a questionnaire regarding the patients’ satisfaction with the method of postoperative pain treatment in the first 48 h. After a 6-month period, all patients were interviewed to evaluate the incidence and possible severity of CPSP. Results: Satisfaction scores were significantly lower in the QLB group than in the control group (p = 0.0000). There were no significant differences between the QLB and control groups regarding the occurrence of chronic postsurgical pain after 6 months following CS (p = 0.102). No statistical differences between the groups were recorded when we compared the results of the questionnaire after a period of 48 h from CS (the number of participants were limited in number). Conclusions: QLB type I is an analgetic option that increased the satisfaction of parturients with pain therapy after CS compared to patients who did not receive the block, and there is a tendency for a lower incidence of CPSP.

Introduction: The post-dural puncture headache (PDPH) is one of the frequently mentioned outcomes of procedures involving spinal taps, spinal anesthesia, or inadvertent puncture of the dura during epidural anesthesia. Aim: The aim of this review is to thoroughly investigate the PDPH problem in anesthesiologist’ daily practice. Material and methods: The work is based on the available literature concerning the topic of PDPH and the author’s experience. Results and discussion: PDPH presents as persistent pain along with potential accompanying symptoms. The PDPH entails a multifaceted process incorporating diverse neurobiological and neurophysiological elements. Various factors directly impact the occurrence rate of PDPH, including the gauge of the epidural anesthesia needle utilized, patient medical history, and numerous other variables. The treatment varies depending on the intensity of symptoms and how long they last. One of the novel treatment options is sphenopalatine ganglion blockade. Conclusions: A comprehensive investigation of this matter should alert medical personnel to the significant issue of PDPH and help prevent its onset.